145 related articles for article (PubMed ID: 12740258)
21. Determinants of airflow obstruction in severe alpha-1-antitrypsin deficiency.
Demeo DL; Sandhaus RA; Barker AF; Brantly ML; Eden E; McElvaney NG; Rennard S; Burchard E; Stocks JM; Stoller JK; Strange C; Turino GM; Campbell EJ; Silverman EK
Thorax; 2007 Sep; 62(9):806-13. PubMed ID: 17389752
[TBL] [Abstract][Full Text] [Related]
22. Survival and FEV1 decline in individuals with severe deficiency of alpha1-antitrypsin. The Alpha-1-Antitrypsin Deficiency Registry Study Group.
Am J Respir Crit Care Med; 1998 Jul; 158(1):49-59. PubMed ID: 9655706
[TBL] [Abstract][Full Text] [Related]
23. Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.
Strange C; Senior RM; Sciurba F; O'Neal S; Morris A; Wisniewski SR; Bowler R; Hochheiser HS; Becich MJ; Zhang Y; Leader JK; Methé BA; Kaminski N; Sandhaus RA;
Ann Am Thorac Soc; 2015 Oct; 12(10):1551-60. PubMed ID: 26153726
[TBL] [Abstract][Full Text] [Related]
24. Variability of pulmonary function in alpha-1-antitrypsin deficiency: clinical correlates.
Silverman EK; Pierce JA; Province MA; Rao DC; Campbell EJ
Ann Intern Med; 1989 Dec; 111(12):982-91. PubMed ID: 2596778
[TBL] [Abstract][Full Text] [Related]
25. Change in lung function and morbidity from chronic obstructive pulmonary disease in alpha1-antitrypsin MZ heterozygotes: A longitudinal study of the general population.
Dahl M; Tybjaerg-Hansen A; Lange P; Vestbo J; Nordestgaard BG
Ann Intern Med; 2002 Feb; 136(4):270-9. PubMed ID: 11848724
[TBL] [Abstract][Full Text] [Related]
26. Exhaled nitric oxide in patients with PiZZ phenotype-related alpha1-anti-trypsin deficiency.
Malerba M; Clini E; Cremona G; Radaeli A; Bianchi L; Corda L; Pini L; Ricciardolo F; Grassi V; Ambrosino N
Respir Med; 2001 Jun; 95(6):520-5. PubMed ID: 11421511
[TBL] [Abstract][Full Text] [Related]
27. Respiratory symptoms and lung function in young adults with severe alpha(1)-antitrypsin deficiency (PiZZ).
Piitulainen E; Sveger T
Thorax; 2002 Aug; 57(8):705-8. PubMed ID: 12149531
[TBL] [Abstract][Full Text] [Related]
28. Linkage analysis of alpha 1-antitrypsin deficiency: lessons for complex diseases.
Silverman EK; Mosley JD; Rao DC; Palmer LJ; Province MA; Elston RC; Weiss ST; Campbell EJ
Hum Hered; 2001; 52(4):223-32. PubMed ID: 11713419
[TBL] [Abstract][Full Text] [Related]
29. Does alpha1-antitrypsin augmentation therapy slow the annual decline in FEV1 in patients with severe hereditary alpha1-antitrypsin deficiency? Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen (WATL) alpha1-AT study group.
Seersholm N; Wencker M; Banik N; Viskum K; Dirksen A; Kok-Jensen A; Konietzko N
Eur Respir J; 1997 Oct; 10(10):2260-3. PubMed ID: 9387950
[TBL] [Abstract][Full Text] [Related]
30. Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ).
Piitulainen E; Eriksson S
Eur Respir J; 1999 Feb; 13(2):247-51. PubMed ID: 10065663
[TBL] [Abstract][Full Text] [Related]
31. Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline.
Dowson LJ; Guest PJ; Stockley RA
Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 1):1805-9. PubMed ID: 11734427
[TBL] [Abstract][Full Text] [Related]
32. The Swedish α1-Antitrypsin Screening Study: Health Status and Lung and Liver Function at Age 34.
Tanash HA; Nystedt-Düzakin M; Montero LC; Sveger T; Piitulainen E
Ann Am Thorac Soc; 2015 Jun; 12(6):807-12. PubMed ID: 25803183
[TBL] [Abstract][Full Text] [Related]
33. Declining FEV1 and chronic productive cough in cigarette smokers: a 25-year prospective study of lung cancer incidence in Tecumseh, Michigan.
Islam SS; Schottenfeld D
Cancer Epidemiol Biomarkers Prev; 1994 Jun; 3(4):289-98. PubMed ID: 8061576
[TBL] [Abstract][Full Text] [Related]
34. Respiratory symptoms and lung function in 30-year-old individuals with alpha-1-antitrypsin deficiency.
Bernspång E; Sveger T; Piitulainen E
Respir Med; 2007 Sep; 101(9):1971-6. PubMed ID: 17532199
[TBL] [Abstract][Full Text] [Related]
35. Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis.
Silverman EK; Chapman HA; Drazen JM; Weiss ST; Rosner B; Campbell EJ; O'DONNELL WJ; Reilly JJ; Ginns L; Mentzer S; Wain J; Speizer FE
Am J Respir Crit Care Med; 1998 Jun; 157(6 Pt 1):1770-8. PubMed ID: 9620904
[TBL] [Abstract][Full Text] [Related]
36. Deficient alpha-1-antitrypsin phenotypes and persistent airflow limitation in severe asthma.
van Veen IH; ten Brinke A; van der Linden AC; Rabe KF; Bel EH
Respir Med; 2006 Sep; 100(9):1534-9. PubMed ID: 16476537
[TBL] [Abstract][Full Text] [Related]
37. Molecular diagnosis of intermediate and severe alpha(1)-antitrypsin deficiency: MZ individuals with chronic obstructive pulmonary disease may have lower lung function than MM individuals.
Dahl M; Nordestgaard BG; Lange P; Vestbo J; Tybjaerg-Hansen A
Clin Chem; 2001 Jan; 47(1):56-62. PubMed ID: 11148177
[TBL] [Abstract][Full Text] [Related]
38. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor.
Wencker M; Fuhrmann B; Banik N; Konietzko N;
Chest; 2001 Mar; 119(3):737-44. PubMed ID: 11243951
[TBL] [Abstract][Full Text] [Related]
39. Prevalence of alpha-1 antitrypsin high-risk variants in Mexican mestizo population and their association with lung function values.
Pérez-Rubio G; Jiménez-Valverde LO; Ramírez-Venegas A; Camarena Á; Sansores RH; Flores-Trujillo F; Reséndiz-Hernández JM; Falfán-Valencia R
Arch Bronconeumol; 2015 Feb; 51(2):80-85. PubMed ID: 25454901
[TBL] [Abstract][Full Text] [Related]
40. Outdoor air pollution is associated with rapid decline of lung function in alpha-1-antitrypsin deficiency.
Wood AM; Harrison RM; Semple S; Ayres JG; Stockley RA
Occup Environ Med; 2010 Aug; 67(8):556-61. PubMed ID: 20519748
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
